Antibodies portfolio : GEMAC

Quick search

Custom Antibodies

Development Strategy

Distributors

To meet us

Contact

Our new products

Anti-idiotypic antibodies
Monoclonal anti-anti-5-hydroxy tryptamine (Serotonin) antibodies (mouse)
Polyclonal anti-anti-Dopamine antibodies (rabbit)
Drugs and NO-drugs
Polyclonal anti-conjugated Tetrodotoxin antibodies (rabbit)
Polyclonal anti-conjugated Valproic acid antibodies (rabbit)
Oxidative products and metabolites
Polyclonal anti-conjugated Malondialdehyde antibodies (rabbit)
Polyclonal anti-conjugated Kynurenic acid antibodies (rabbit)
Polyclonal anti-conjugated Quinolinic acid antibodies (rabbit)
Polyclonal anti-conjugated L-Kynurenine antibodies (rabbit)
Neurotoxic products
Polyclonal anti-conjugated Kainic acid antibodies (rabbit)
Polyclonal anti-conjugated Rotenone antibodies (rat)
Nitrosylated compounds
Monoclonal anti-conjugated Nitrosocysteine antibodies (mouse)
Polyclonal anti-conjugated Nitrosocitrulline antibodies (rabbit)
Plants
Polyclonal anti-conjugated Abscisic acid antibodies (rabbit)
Polyclonal anti-conjugated Gibberellic acid antibodies (rat)
Polyclonal anti-conjugated 3-indolacetic acid antibodies (rabbit)
Scavenger molecules and vitamins
Polyclonal anti-conjugated Pyridoxine (vitamin B6) antibodies (rat)
Polyclonal anti-conjugated riboflavine (vitamin B2) antibodies (rat)
Polyclonal anti-conjugated Thiamine (vitamin B1) antibodies (rat)

Polyclonal anti-conjugated NO-Histidine antibodies (AP070)

NO-Histidine immunoreactivity on lumbar spinal cord of transgenic rat model of ALS (left), versus rat control (right). (NICAISE et al., COST B30 meeting, November 13-14, 2006, Carmona, Spain)